Clinical Trials Directory

Trials / Unknown

UnknownNCT03831685

Blood Lactate Level for Pre-hospital Orientation of Septic Shock

Contribution of Pre-hospital Blood Lactate Level for Pre-hospital Orientation of Septic Shock

Status
Unknown
Phase
Study type
Observational
Enrollment
1,000 (estimated)
Sponsor
Hôpital Necker-Enfants Malades · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

In the pre-hospital setting, the severity assessment of septic shock is essential to decide the optimal initial in-hospital level of care. As clinical signs can be faulted, there is a need for an additional element in order to enhance the severity assessment and to decide in-hospital admission in the intensive care unit (ICU) or in the emergency department (ED). Point of care medical device yielding blood lactate levels since the pre-hospital setting may give an easy and valuable element for the severity assessment and the decision-making. The aim of this study is to provide clinical evidence that the pre-hospital blood lactate level predicts the 30-day mortality of patients with septic shock.

Detailed description

This trial is a prospective, observational, non-randomized controlled study. A total of 1000 patients requiring mobile intensive care unit intervention for a septic shock in the pre-hospital setting will be included. Pre-hospital blood lactate levels will not be taken into account to decide patients treatments and/or ED or ICU admission. In the pre-hospital setting, each patient will benefit from 2 measurements of blood lactate level: initial measurement at the first contact, and final measurement at the hospital admission with a specific point of care medical device.

Conditions

Interventions

TypeNameDescription
OTHERBlood samplePatients meeting the inclusion criteria and none of the non-inclusion criteria will benefit from 2 venous blood samples in order to precise the initial blood lactate level, e.g. at the first medical contact, and the final blood lactate level, e.g. at the hospital admission.

Timeline

Start date
2018-03-01
Primary completion
2022-03-01
Completion
2022-03-01
First posted
2019-02-06
Last updated
2019-02-11

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03831685. Inclusion in this directory is not an endorsement.